Lung cancer showdown: surgery vs. radiation – which works better?

NCT ID NCT05183932

Ongoing Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 17 times

Summary

This study compares two standard treatments for stage I non-small cell lung cancer: surgery and stereotactic body radiation therapy (SBRT). About 446 patients are being followed for up to 3 years to see which treatment leads to better disease-free survival and quality of life. The goal is to help doctors and patients choose the best option for early-stage lung cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Carle Cancer Institute

Urbana, Illinois, 61801, United States
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Duke University

Durham, North Carolina, 27710, United States
Emory University

Atlanta, Georgia, 30322, United States
Memorial Sloan Kettering

New York, New York, 10065, United States
University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
University of Toronto

Toronto, Ontario, Canada
Washington University School of Medicine

St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER